Introduction
============

Many studies have been dedicated to efficient screening and identification of causative genes and pathways implicated in cancerous phenotypes. Much attention has been drawn to gene prioritization that helps to select from a large number of candidate genes a subset of those that are biologically most relevant and are worth further validation experiments.

To understand the pathophysiological mechanisms, it is insufficient to investigate only at the level of single-nucleotide polymorphisms (SNPs) or copy number variations (CNV) as in genome-wide association study (GWAS). This is partly due to the lack of statistical strength that plagues GWAS,[@b1-cin-suppl.1-2014-069] which stems from the need to correct for multiple testing, and makes it difficult to implicate causative genes. On the other hand, cancers that involve complex and epistatic genetic traits cannot be adequately explained by additive genetic models. Moreover, cancer phenotypes necessarily involve the full scope of Omics including genomics, transcriptomics, epigenomics, proteomics, and metabolomics, as well as their interaction and correlation with pheno-types. Rather, levels in the Omic hierarchy need to be considered simultaneously and interactively. This is because the genes, RNAs, proteins, and epigenetic factors interplay in the form of signaling networks, metabolic networks, regulatory networks, etc. Moreover, biological networks further interact and exchange information among each other, as shown in [Figure 1](#f1-cin-suppl.1-2014-069){ref-type="fig"}.

The importance of the integrated Omic view toward cancer is increasingly realized, and drives collaborative efforts toward development of shared expression, functional annotation, protein--protein interaction (PPI) network, experimental Omic data sources, literature, etc. Most data sources are structured and have predefined schemas for prioritization tools to follow. In fact, gene prioritization tools have been progressively refining their customized components for analyzing structured data sources; see reviews.[@b2-cin-suppl.1-2014-069]--[@b5-cin-suppl.1-2014-069] In contrast, text mining methods on literature data source and text descriptions in structured data sources have seen slow progress. Thus unlike previous reviews, this review focuses on the text mining methodology used in gene prioritization tools and recent developments on the emerging direction of pathway prioritization.

Heterogeneous Data Sources
==========================

With recent advances in the Omic era, large volumes of data are gathered from multiple levels of the Omic hierarchy including genome, transcriptome, epigenome, proteome, and metabolome. These data sources may focus on different subsets of the Omic hierarchy. These data sources also present themselves in various formats such as sequence reads, numerical expression levels, and narrative text in the scientific literature. The increasing availability of high throughput technology such as next-generation sequencing (NGS) not only calls for a changing perspective on the Omic model, but also calls for upgrading hypotheses, algorithms, and software that integrate the evolution of knowledge. In particular, in addition to subsequent analysis on GWAS results to accumulate evidence by statistical procedures,[@b6-cin-suppl.1-2014-069] gene prioritization methods also need to integrate an increasing number of heterogeneous data sources, in terms of both content and data formats.

There are a multitude of data sources that encode different types of information regarding the Omic hierarchy and information exchange. These data sources have been conventionally categorized based on their purposes, for example, functional annotation, ontologies, and sequence data. Here, we try to summarize the currently active data sources that have been used by gene prioritization tools as well as by cancer biologists and clinicians in their routine research and practice, grouping them according to their primary utility categories. [Table 1](#t1-cin-suppl.1-2014-069){ref-type="table"} lists the summarized data sources. From the table it can be seen that many data sources contain narrative text or literature, suggesting the broad applicability of text mining to gene prioritization. Thus closer understanding and more improvements on text mining methods in gene prioritization is likely to make a general impact.

Text Mining in Gene Prioritization
==================================

This section provides an extensive review of computational tools for gene prioritization. Because we are focusing on text mining in such tools, we categorize them according to the characteristics of their text mining components. In each category, prioritization methods are ordered chronologically.

Prioritization without text mining
----------------------------------

Despite the prevalence of literature and narrative text segments in many data sources, earlier gene prioritization methods may leave out the text mining component and simply rely on mining structured data.

POCUS[@b80-cin-suppl.1-2014-069] relies on statistics composed of term IDs in functional annotation databases that are shared by gene-- disease pairs. PROSPECTR[@b81-cin-suppl.1-2014-069] uses alternating decision trees to classify whether the candidate genes and known disease genes share similar sequence patterns. Gentrepid[@b82-cin-suppl.1-2014-069] is directly based on biological data including protein domain similarity, protein interaction, and pathway membership. PhenoPred[@b83-cin-suppl.1-2014-069] is a supervised method based on experimental PPI networks, protein--disease association, protein sequences, and protein function annotations. PhenoPred encodes gene features using shortest-path distances to all disease genes or genes with known function annotation, as well as sequence and function features using physicochemical or predicted structural properties (real-valued) and GO terms and PROSITE patterns. Principal component analysis (PCA)[@b84-cin-suppl.1-2014-069] was used to reduce dimensionality and support vector machine (SVM)[@b85-cin-suppl.1-2014-069] was used to predict individual disease--gene correlation.

Prioritization with keyword search text mining
----------------------------------------------

Prioritization methods falling in this category rely on key-word matching when retrieving literature or text segment in response to query terms such as phenotype descriptions or gene names. Indexing is frequently performed to preprocess the narrative text in data sources in order to categorize the literature and reduce the search time.

GeneSeeker[@b86-cin-suppl.1-2014-069] depends on gene positional data and expression data, as well as phenotype data extracted using keyword search from MEDLINE and OMIM. GeneSeeker uses synonym lists compiled from Swiss-Prot and the now inactive Human Genome Database[@b87-cin-suppl.1-2014-069] to unify nomenclature across different data sources. Prioritizer[@b88-cin-suppl.1-2014-069] constructs the gene network using Bayesian integration to account for both manually curated protein interaction and pathway information as well as co-expression data, yeast-two-hybrid (Y2H) interaction data, etc. To initialize the network, known contributing genes are identified by text mining on the OMIM disease entries. CANDID[@b89-cin-suppl.1-2014-069] asks the users to input keywords related to the traits of interest and uses them to query the literature and protein domain descriptions (keyword matching). CAN-DID also uses other data sources to generate source-specific numeric scores, such as those on phylogenetic conservation, gene expression, protein interactions, linkage, SNP association, and user provided gene scores.

All source-specific scores are merged into a final score by user provided weights. PGMapper[@b90-cin-suppl.1-2014-069] uses keywords to search phenotype databases such as OMIM and PubMed, and combines linkage, expression, and sequence data sources to search candidate genes for 16 species including human. GeneProspector[@b91-cin-suppl.1-2014-069] keeps an in-house literature database by first using text mining to screen PubMed, and then having curators review and manually index screened abstracts. Indexing tasks include associating the publications with gene symbols, predefined categories, and study types, in order to calculate a heuristic score for each gene. MaxLink[@b92-cin-suppl.1-2014-069] relies on clues based on connectivity of candidate genes to the known disease genes in a PPI network to rank genes and uses keyword searches to provide known gene sets.

Prioritization with vector space model based text mining
--------------------------------------------------------

Vector space model represents text document and segments as vectors of identifiers, eg, index terms. Compared with keyword search, vector space model can take into consideration counts and weights of index terms. Vector space model based text mining is frequently explored in gene prioritization tools.

G2D[@b93-cin-suppl.1-2014-069]--[@b95-cin-suppl.1-2014-069] performs text mining on MEDLINE to associate MeSH phenotype terms with MeSH chemistry terms and to associate MeSH chemistry terms with GO terms. For both associations, co-occurrence statistics are calculated. Association between MeSH phenotype terms and GO terms is then calculated transitively from the two associations, based on fuzzy set theory. G2D then searches the RefSeq and STRING databases and assigns gene score by averaging across GO terms matching that gene. SNPs3D[@b96-cin-suppl.1-2014-069] uses text profiling on MEDLINE abstracts to rank candidate genes. More specifically, the authors collected nouns and adjectives as keywords, tallied the raw counts of keywords and gene--keyword pairs within the corpus, devised heuristic scores for gene--gene interaction and disease--gene, and applied a rule-based approach to assign the final rank. MimMiner[@b97-cin-suppl.1-2014-069] uses the anatomy and the disease sections of MeSH to extract terms from OMIM records and builds a vector space model, weighting the vector element according to the MeSH hierarchy and inverse document frequency. The authors reported correlations between phenotype similarity and gene sequence similarity, correlations between phenotype similarity and protein interaction, correlations between phenotype similarity and gene functions in pathways, and the implication of phenotype grouping on the modular nature of human disease genes, all derived from text mining. Endeavour[@b98-cin-suppl.1-2014-069],[@b99-cin-suppl.1-2014-069] trains separate models on different data sources including literature, functional annotation, gene expression, protein domains, protein interactions, pathway membership, cis-regulatory modules, transcriptional motifs, sequence similarity, and user provided data. Endeavour then ranks the target genes against individual models and pools the individual ranks to get an overall rank, using a customized Q-statistic. CAESAR[@b100-cin-suppl.1-2014-069] accepts as input a text excerpt containing previously implicated genes, performs text mining (vector-space model) against phenotypic, anatomic, and genetic ontologies and extracts ontology terms. CAESAR then maps such terms to candidate genes in expression, interaction, and pathway data sources and generates data-source specific gene scores that are in turn aggregated into a final score. ToppGene[@b101-cin-suppl.1-2014-069],[@b102-cin-suppl.1-2014-069] uses co-citation counts in PubMed as an indication of gene relationship. Using data sources covering gene, protein, and pathway; ToppGene implements two gene prioritization systems: one based on function annotation and the other based on interaction network. CIPHER[@b103-cin-suppl.1-2014-069] is a network based prioritization method integrating PPI networks, disease phenotype similarity, and known gene--phenotype associations. CIPHER uses the text mining component of MimMiner[@b97-cin-suppl.1-2014-069] to calculate phenotype similarity. GeneDistiller[@b104-cin-suppl.1-2014-069] uses literature co-occurrence statistics to filter the candidate genes, besides integrating data sources on genes, proteins, and pathways. PRINCE[@b105-cin-suppl.1-2014-069] is a network based algorithm that not only predicts gene associations but also infers protein complex associations with diseases. The construction of the network begins with scanning causal genes of known diseases that share phenotype similarity to the target disease, where the authors used the MeSH based phenotype similarity metric from MimMiner.[@b97-cin-suppl.1-2014-069] The network is then initialized with prior knowledge and gene scores are computed using an iterative network propagation algorithm. The web tool PolySearch[@b106-cin-suppl.1-2014-069] searches PubMed abstracts as well as gene, protein, pathway, and metabolite data sources to integrate their text content. PolySearch manually curates a corpus consisting of terms and synonyms from dictionaries compiled from gene function databases. PolySearch also adopts a heuristic scoring system to rank disease queries and matching gene terms where scoring is based on a discretized sentence relevancy. Gene-Wanderer[@b107-cin-suppl.1-2014-069] applies random walk and diffusion kernel on PPI networks and compares the PPI domain knowledge collected with and without text mining. The authors pointed out that integrating literature data may lead to better performance on retrospective studies than prospective settings, a phenomenon referred to as "knowledge contamination" as retrospective knowledge is already present in the literature. GPsy[@b108-cin-suppl.1-2014-069] profiles candidate genes using data sources on gene sequence, expression, function annotation, and gene--disease association, augmented with orthologous genes extracted from Homolo-Gene[@b77-cin-suppl.1-2014-069] and OMA (Orthologous MAtrix).[@b78-cin-suppl.1-2014-069] Text mining is used to extract phenotype annotation based on co-occurrence statistics in the biomedical literature.

Prioritization with text mining using ontology structure
--------------------------------------------------------

In addition to using vector space model and using ontology only as a terminology mapping tool, gene prioritization methods in this category further explore the ontology structure (eg, the is-a relation between parent and child nodes in an ontology), in order to better quantify the semantic similarity between concepts.

Tiffin et al.[@b109-cin-suppl.1-2014-069] use the eVOC anatomical ontology to combine literature text mining and gene expression data. The eVOC terms serve as a bridge to connect the PubMed literature (via association frequency between eVOC term and disease names) and RefSeq genes (via frequency of RefSeq genes annotated with eVOC terms). A heuristic ranking score is then used to prioritize the bridged disease--gene pair. SUSPECTS[@b110-cin-suppl.1-2014-069] uses four data sources including gene sequence patterns (obtained from PROSPECTR), gene expression, shared rare protein domains, and semantic similarity of the associated GO terms between the candidate and seed genes. The calculation of semantic similarity is done using the metric of information content proposed by Lord et al.^111,^ which is based on counting how many times a GO term occurs in the Swiss-Prot database. MedSim[@b112-cin-suppl.1-2014-069] uses GO terms as the function annotation of a gene and experiments with multiple configurations on whether to include GO terms of ortholog genes, interacting genes, or semantically similar GO terms. The semantic similarity is calculated with the simRel score, taking into account the differences, commonalities, and specificities of GO terms.[@b113-cin-suppl.1-2014-069]

Prioritization with statistical text mining
-------------------------------------------

Recently, statistical text mining in gene prioritization has gained traction, where a pre-defined distribution or a Bayesian model is used to fit the data in order to boost the prediction power.

GRAIL[@b114-cin-suppl.1-2014-069] is a text mining approach that resembles correlating gene pathways to diseases in that it identifies not only the disease genes but also their biological relationships. GRAIL takes seeds from the implicated SNPs identified by GWAS to anchor seed chromosomal regions, so it is less susceptible to knowledge contamination. A gene is represented as a feature vector by using a term frequency-inverse document frequency (tf--idf) weighted vector space model to analyze the PubMed corpus, from which the relatedness between genes can be calculated and connections between candidate genes and seed regions (containing implicated genes) can be made. By fitting a Poisson distribution over the connections between candidate genes and seed regions, a *P*-significance can be calculated to show how likely a candidate gene is implicated. Besides text similarity-based gene relatedness, GRAIL also calculates annotation-based relatedness and expression-based relatedness to quantify biological relations between genes. Genie[@b115-cin-suppl.1-2014-069] is a literature-based prioritization method that mines MEDLINE abstracts and explores orthologs to identify more abstracts containing related orthologous genes to complement the genes of under studied organisms. In order to retrieve orthologous genes, a sample set of abstracts with the genes from the target organism is used to train a Bayesian linear classifier that picks discriminative keywords to be used in orthologous gene abstract search. MetaRanker[@b116-cin-suppl.1-2014-069] applies large-scale text mining on all MEDLINE abstracts available by then using customized statistical models of genes and MeSH terms adjusting for publication bias, similar to GRAIL. In addition, MetaRanker also integrates GWAS SNP--phenotype associations, PPI networks, linkage analysis data, gene expression, CNV, and user provided NGS data.

There are also efforts toward comparing and integrating computational tools for correlating candidate genes, such as gene prioritization portal^117,^ which links to 19 previous computational solutions. In Ref. [@b118-cin-suppl.1-2014-069], the authors compared algorithms that use PPI networks including network neighbor analysis, unsupervised clustering, semi-supervised clustering, network flow with prior information, and random walks, and reported superior performance of random walk on network data. Although both works did not have text mining as their focus, they can potentially shed lights on best practice when integrating analysis on structured data with text mining in gene prioritization. They also serve to illustrate the imbalance between the advances in mining structured data and mining text in gene prioritization, which is readily evidenced by the complexity of models employed. We summarize the text mining components in the above gene prioritization methods in [Table 2](#t2-cin-suppl.1-2014-069){ref-type="table"}, grouped using the same categorization as we introduced these methods. We also briefly comment the advantages and disadvantages of the text mining components.

Challenges of Text Mining in Gene Prioritization
================================================

From the progression of gene prioritization methods over time as summarized in the previous section, it becomes clear that the application of text mining has seen slow methodology advance. In our opinion, the evidence from the literature has been largely treated in an oversimplified fashion. This section lays out some of the challenges encountered by text mining in gene prioritization, and the next section enumerates several promising directions emerged lately.

Noisy, contaminated and biased knowledge
----------------------------------------

Representation of gene--disease relations extracted by current text mining in gene prioritization is often noisy because of the insufficient level of detail in co-occurrence counts or simple statistics. Mined relations are also biased toward genes and phenotypes that are already present in the literature and may offer only limited insights to new discoveries. This effect of knowledge contamination is said to make the prioritization task easier for retrospective discovery than for novel discovery. In fact, this problem is not specific to text mining only, because after publication in literature, knowledge is also quickly integrated into structured data in sources such as KEGG, STRING, and InterPro. Thus cross-validation based methods for checking generalizability may not guarantee good performance on novel genes. Previous works usually tried to reduce such overestimation by sub-setting data prior to the real discovery of the cross-validated genes. However, this does not eliminate another, more subtle form of knowledge contamination, as literature based text mining may still present bias toward existing concepts about the disease. GRAIL addressed this problem by not using known pathways and genes at all, but increased the risk of reinventing the wheel for known discoveries. A finer statistical approach should be devised to utilize existing knowledge and eliminate or offset the potential bias.

Evaluation of text mining components in gene prioritization methods
-------------------------------------------------------------------

Ideally, we need objective evaluation for this ever expanding array of text mining components in gene prioritization methods. In typical text mining settings, a ground truth needs to be established as a gold standard to perform intrinsic evaluation and compare different text mining approaches as isolated systems. For example, in a related task of extracting mentions of genes from documents, experts need to first manually annotate the corpora and mark the gene mentions. With such a ground truth produced, evaluation metrics such as precision, recall, and *f*-measure can be used to assess the effectiveness of text mining approaches in recognizing gene mentions. Let TP denote the number of true positives in the contingency table, FP denote the number of false positives, and FN denote the number of false negatives, the definition of precision is *P* = *TP*/(*TP* + *FP*), recall is *R* = *TP*/(*TP* + *FN*), *f*-measure is *F* = 2 × *P* × *R*/(*P* + *R*). However, the task of text mining for gene prioritization is more involved, and the structure of the ground truth is less obvious. This is further complicated by the fact that text mining is embedded inside the pipeline of gene periodization as one component, which often requires extrinsic evaluation that assesses the performance of the overall task. Because of the explorative nature of gene prioritization tasks, experimental bench-marking and statistical benchmarking by cross-validation are frequent choices of assessing prioritization methods.[@b2-cin-suppl.1-2014-069] Experimental benchmarking requires lab experiments to determine the proportion of false positives in the top ranked genes. Statistical benchmarking requires known disease-associated genes and evaluates how well the top ranked genes overlap with the known set of genes. Note that both benchmarking evaluations are necessary but not sufficient conditions for a good prioritization.

Problems with guilt-by-association
----------------------------------

Network based gene prioritization methods integrate evidence from text mining and similarity profiling, as well as function and interaction annotations. The assumption shared by those methods is the so called Guilt-by-Association (GBA), which states that functionally related genes will give rise to similar mutational phenotypes. GBA has been used to statistically infer previously unknown functions of a gene from prior knowledge about known genes and association data such as PPI and co-expression. However, recent studies have shown that GBA may not in general hold true.[@b119-cin-suppl.1-2014-069],[@b120-cin-suppl.1-2014-069] Further, most prioritization tools do not distinguish the types of gene relations, hence they are "black-box" in nature. The black-box nature is partly responsible for the poor performance of GBA. Typically, the construction of functional networks is done by aggregating context independent data such as physical PPI and context specific data such as co-expression[@b121-cin-suppl.1-2014-069] without distinguishing them. This is especially true for gene and protein interactions extracted from literature using text mining with simple co-occurrence or co-citation statistics. Separating context specific evidence may lend better insights to improve the robustness of the results.[@b122-cin-suppl.1-2014-069] Thus taking finer semantic information into text mining consideration is likely to improve the accuracy of the mined relations. For example, distinguishing "gene A promotes expression of gene B", "gene A inhibits gene B," and "gene A inhibits gene B under the co-expression of gene C" will produce more context specific relations and networks than "gene A and gene B are related". Further, improving explanatory power can also help elucidate molecular mechanisms of major pathways that underlie cancer development.

Heterogeneous data sources
--------------------------

In gene prioritization, multiple heterogeneous data sources often need to be taken into account, such as expression level, protein interaction, domain interaction, sequence reads, and literature data. Although previous works strive for increasingly comprehensive coverage for those data sources, to date none covers all data sources. Moreover, the inter-operative information exchanges between data sources in previous gene prioritization approaches are largely based on customized ontology and keyword term matching. On the other hand, most gene prioritization methods analyze different types of evidence separately and only pool scores produced by individual types of evidence at a later stage. In keeping with the integrative Omic view in [Figure 1](#f1-cin-suppl.1-2014-069){ref-type="fig"}, data integration should happen at an earlier stage so that reasoning can be on a more integrative level: "enrichment in expression of gene A" (expression evidence) and "protein A binds protein B" (PPI evidence) together implicate a phenotype C. This level of integration is yet to be achieved and there is still no principled way to construct a unified reasoning platform across data sources.

Cross-species insights
----------------------

There are genetic knowledge bases describing thoroughly studied model organisms, such as gene--phenotype associations in mouse, worm, fly, and yeast in the STRING database. They can be leveraged to draw insights into human pathways that are not as heavily investigated, through orthologous genes,[@b79-cin-suppl.1-2014-069] or through cross-species annotation transfer of interolog PPIs.[@b123-cin-suppl.1-2014-069] In fact, some gene prioritization methods have exploited ortholog and interolog data sources to cover the understudied human cancer phenotypes or genes, using either manually curated lists (eg, GPsy[@b108-cin-suppl.1-2014-069]) or text mining on the literature (eg, MedSim,[@b112-cin-suppl.1-2014-069] Genie[@b115-cin-suppl.1-2014-069]). However, transferring knowledge across species remains a significant challenge as biological context and environmental factors also contribute to the ways genes and proteins interact. Thus, there is no guaranteed mapping from sequence similarity to functional similarity. For this reason, we also expect that taking finer semantic information into text mining consideration to provide context specificity to ortholog and interolog gene relations is likely to help the overall prioritization task.

Emerging and Future Directions
==============================

This section presents several recent advances that may provide partial solutions to some challenges raised in the analysis of the previous section.

Converting literature and clinical records to networks
------------------------------------------------------

The task of automatically annotating biomedical text with semantic information is an area of active research of medical Natural Language Processing (NLP). There are existing methods that extract named entities such as genes and proteins, as well as their relations (see related work section of[@b124-cin-suppl.1-2014-069] for an overview). Previous gene prioritization methods have partially used these methods to identify gene and protein names, but not as much their relations, when constructing gene and protein networks. This is partly due to the fact that most NLP based semantic relation extraction tools identify only binary relations that are too coarse for gene prioritization tasks so that they do not offer much more information compared to simple co-occurrence statistics. Recently, Luo et al.[@b124-cin-suppl.1-2014-069] proposed an algorithm that translates text into a network representation, where the nodes of the network may be nominal concepts such as genes and proteins or relational concepts such as a verb specifying an interaction. The edges are syntactic dependency links. We give an example sentence--network translation in [Figure 2](#f2-cin-suppl.1-2014-069){ref-type="fig"}, which shows the network representation for a sentence from the first paragraph in an example paper,[@b125-cin-suppl.1-2014-069] along with two of its sub-networks.

Given the text translated networks, useful sub-networks can be harvested under predefined criteria (eg, frequency, *P*-significance, or other customized criteria). With proper set criteria, sub-networks may be chosen to represent context specific associations between genes and proteins.

Pathway prioritization
----------------------

Most gene prioritization methods only focus on using network analysis to rank genes' relatedness to diseases. A particular gene often participates in multiple pathways, yet maybe only some of those pathways are implicated in a cancer phenotype. Moreover, existing pathways may only have part of themselves involved in a disease process. To this end, associating and prioritizing genetic networks or sub-networks instead of genes can be both more discriminative and more informative, to identify new pathways. Finding cancer correlated pathways is mostly carried out on a case-by-case basis, targeting specific cancer types (eg, [@b126-cin-suppl.1-2014-069],[@b127-cin-suppl.1-2014-069]). Moreover, identifying such pathways often starts from implicating candidate genes, and known functional pathways are then filtered (sometimes manually) based on prior knowledge. In reality, cancer pathogeneses range from monogenic and oligogenic disorders to complex and epistatic disorders. Direct identification of carcinogenesis pathways may provide more intuition about the underlying molecular mechanisms and hence be more amenable for experimental biologists to start with. On the other hand, gene prioritization methods on direct identification of pathways involved in carcinogenesis have been studied little. GRAIL can be seen as an initial step toward this goal in that it identifies biological relationships among the genes in addition to ranking them. However, GRAIL does not identify what types of relations hold between genes. Hence the predicted genes plus their relationships do not form a pathway as they lack putative mechanism information. The aforementioned text-to-network translation tool may be used for producing context specific gene associations with detailed relation types in order to "build the bridge to the pathway".

Conclusions
===========

In this review, we focused on text mining in gene prioritization approaches, which is demonstrably an important component because of the large volume and the prevalence of the biomedical literature and narrative text across many heterogeneous data sources. We reviewed and categorized gene prioritization text mining methods according to progressively advanced models employed, and pointed out that they have seen slower advances compared to the other components in gene prioritization that analyze structured data. We discussed several key challenges to text mining in gene prioritization. We also identified promising future directions including text--network translation to provide finer semantic information and pathway prioritization to offer more mechanism information.
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Data sources for gene and pathway prioritization according to their primary utility.

  UTILITY CATEGORY                       DATA SOURCES
  -------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Literature                             **PubMed**[@b9-cin-suppl.1-2014-069], **MEDLINE**, **OMIM**[@b10-cin-suppl.1-2014-069]
  Terminology & Ontology                 **GO**[@b11-cin-suppl.1-2014-069], **UMLS**[@b12-cin-suppl.1-2014-069], **DO**[@b13-cin-suppl.1-2014-069], **MeSH**[@b14-cin-suppl.1-2014-069], eVOC[@b15-cin-suppl.1-2014-069], **HPO**[@b16-cin-suppl.1-2014-069], **MPO**[@b17-cin-suppl.1-2014-069]
  Pathway                                KEGG[@b18-cin-suppl.1-2014-069], BioCarta[@b19-cin-suppl.1-2014-069], **BioCyc**[@b20-cin-suppl.1-2014-069], **Reactome**[@b21-cin-suppl.1-2014-069], **GenMAPP**[@b22-cin-suppl.1-2014-069], **MSigDB**[@b23-cin-suppl.1-2014-069], **Brenda**[@b24-cin-suppl.1-2014-069], **CTD**, HPRD[@b25-cin-suppl.1-2014-069], **GXD**, **BIND, MGI**, **PharmGKB**, PID[@b26-cin-suppl.1-2014-069]
  Protein sequence & Domain              **InterPro**[@b27-cin-suppl.1-2014-069]**, Aceview**[@b28-cin-suppl.1-2014-069], **Pfam**[@b29-cin-suppl.1-2014-069], SMART[@b30-cin-suppl.1-2014-069], **PROSITE**[@b31-cin-suppl.1-2014-069], Gene3D[@b32-cin-suppl.1-2014-069], **ProDom**[@b33-cin-suppl.1-2014-069], Ensembl, **Swiss-Prot**, **TrEMBL**, HPRD, **RefSeq,** GenBank, **MGI**, **CDD**[@b34-cin-suppl.1-2014-069], **Entrez Gene**[@b35-cin-suppl.1-2014-069]
  Regulation                             **MSigDB**, TargetScan[@b36-cin-suppl.1-2014-069], TRANSFAC[@b37-cin-suppl.1-2014-069], **BioCyc**, **Reactome, Brenda**, TOUCAN
  Gene expression                        Ensembl[@b38-cin-suppl.1-2014-069], BIOGPS[@b39-cin-suppl.1-2014-069], **GEO**[@b40-cin-suppl.1-2014-069], MBA[@b41-cin-suppl.1-2014-069], HBA[@b42-cin-suppl.1-2014-069], **Reactome, GenMAPP, GXD, STRING, MGI, SOURCE**[@b43-cin-suppl.1-2014-069]
  Gene-Protein and Disease               **CTD**[@b44-cin-suppl.1-2014-069], HPRD, **GXD**, **COSMIC**, **TCGA**, **MGI, ClinVar**, NHGRI GWAS, **Phar-mGKB, Orphanet**[@b45-cin-suppl.1-2014-069], HuGENavigator[@b46-cin-suppl.1-2014-069]**, GHR**[@b47-cin-suppl.1-2014-069], **SOURCE**, GAD[@b48-cin-suppl.1-2014-069]
  Gene & Protein variation               Ensembl, **OMIM**, HGMD[@b49-cin-suppl.1-2014-069], **Swiss-Prot**[@b50-cin-suppl.1-2014-069], HPRD, **GXD**[@b51-cin-suppl.1-2014-069], **TrEMBL**[@b52-cin-suppl.1-2014-069], **COSMIC**[@b53-cin-suppl.1-2014-069], **TCGA**[@b54-cin-suppl.1-2014-069], dbSNP[@b55-cin-suppl.1-2014-069], **GEO**, **RefSeq**, **ClinVar**[@b56-cin-suppl.1-2014-069], NHGRI GWAS[@b57-cin-suppl.1-2014-069],[@b58-cin-suppl.1-2014-069], **PharmGKB**[@b59-cin-suppl.1-2014-069], GeneTests[@b60-cin-suppl.1-2014-069], **MGI, CDD, GHR**, ALFRED[@b61-cin-suppl.1-2014-069], HapMap[@b62-cin-suppl.1-2014-069]
  Gene function annotation               **PROSITE**, **GO**, **BioCyc**, **Reactome**, **GenMAPP**, **Brenda**, BIOGPS, **Swiss-Prot**, **TrEMBL**, dbSNP, **MGI, SOURCE**
  Gene, Protein & Chemical interaction   **STRING**[@b63-cin-suppl.1-2014-069], HPRD, **BioGrid**[@b64-cin-suppl.1-2014-069], **BIND**[@b65-cin-suppl.1-2014-069], **IntACT**[@b66-cin-suppl.1-2014-069], DIP[@b67-cin-suppl.1-2014-069], Gene3D, Drugbank[@b68-cin-suppl.1-2014-069], Matador[@b69-cin-suppl.1-2014-069], **CTD**, **Stitch**[@b70-cin-suppl.1-2014-069], **Swiss-Prot**, **TrEMBL**, HPRD, **PharmGKB**, **Entrez Gene**, PID
  Gene sequence & Locus                  BLAST[@b71-cin-suppl.1-2014-069], **RefSeq**[@b72-cin-suppl.1-2014-069], TOUCAN[@b73-cin-suppl.1-2014-069], GenBank[@b74-cin-suppl.1-2014-069], **BioCyc, Brenda**, MBA, HBA, HPRD, **GXD**, **STRING**, **BIND**, **MGI**, **Entrez Gene**
  Homology analysis                      **MGI**[@b75-cin-suppl.1-2014-069],[@b76-cin-suppl.1-2014-069], HomoloGene[@b77-cin-suppl.1-2014-069] and OMA[@b78-cin-suppl.1-2014-069], Inparanoid[@b79-cin-suppl.1-2014-069], **BioCyc, Reactome, GXD**, **Ref-Seq**, **Entrez Gene**

**Notes:** Bold font indicates the source has narrative text and is suitable for text mining. This does not include data sources that only points to literature data sources such as PubMed. We also exclude data sources that are built solely by automatic mining of other data sources, eg, GeneCards.[@b7-cin-suppl.1-2014-069],[@b8-cin-suppl.1-2014-069]

**Abbreviations:** OMIM, Online Mendelian Inheritance in Man; GO, Gene Ontology; UMLS, Unified Medical Language System; DO, Disease Ontology; MeSH, Medical Subject Heading; HPO, Human Phenotype Ontology; MPO, Mammalian Phenotype Ontology; GEO, Gene Expression Omnibus; CTD, Comparative Toxicogenomics Database; GXD, Gene Expression Databas; MGI, Mouse Genome Informatics; HPRD, Human Protein Reference Database; HGMD, Human Gene Mutation Database; MBA, Mouse Brain Atlas; HBA, Human Brain Atlas; CDD, Conserved Domain Database; GHR, Genetics Home Reference; GAD, Genetic Association Database; OMA, Orthologous Matrix.

###### 

Summarization of text mining components in gene prioritization methods.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  CATEGORIZATION            PRIORITIZER                                                                                                                                   TEXT MINING USAGE                                                                                                                        PROS AND CONS OF TEXT MINING METHODS
  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No text mining            POCUS\                                                                                                                                        NA                                                                                                                                       Lack of textual evidence
                            PROSPECTR\                                                                                                                                                                                                                                                                             
                            Gentrepid\                                                                                                                                                                                                                                                                             
                            PhenoPred                                                                                                                                                                                                                                                                              

  Keyword search            GeneSeeker                                                                                                                                    Extract phenotype data                                                                                                                   Requires prior knowledge in selecting and hand tuning keyword sets; subject to selection bias when picking keywords

  Prioritizer               Extract known genes                                                                                                                                                                                                                                                                    

  CANDID                    Match protein domain description                                                                                                                                                                                                                                                       

  PGMapper                  Extract phenotype data                                                                                                                                                                                                                                                                 

  GeneProspector            PubMed screening before reviews by curators                                                                                                                                                                                                                                            

  MaxLink                   Extract known genes                                                                                                                                                                                                                                                                    

  Vector space model        G2D                                                                                                                                           Associate MeSH phenotype terms, MeSH chemistry terms, and GO terms                                                                       Possible to calculate semantic similarities automatically; on the other hand, the accuracy of the semantic similarity will be restricted by the co-occurrence counts of words or citations, which are only approximations for real semantics

  SNPs3D                    Score candidate genes by profiling noun and adjective counts in the MEDLINE abstracts                                                                                                                                                                                                  

  MimMiner                  Extract correlations of pheno-type similarity protein interaction, and gene functions in pathways                                                                                                                                                                                      

  Endeavour                 Rank genes separately on literature evidence, before pooling an overall rank                                                                                                                                                                                                           

                            CAESAR                                                                                                                                        Match database description of genes to ontology descriptions of phenotype, anatomy and genes                                             

  ToppGene                  Use co-citation counts in Pub-Med as indication of gene relationship                                                                                                                                                                                                                   

  CIPHER                    Use the text mining component of MimMiner                                                                                                                                                                                                                                              

  GeneDistiller             Use literature co-occurrence statistics to filter the candidate genes                                                                                                                                                                                                                  

  PRINCE                    Use the text mining component of MimMiner                                                                                                                                                                                                                                              

  PolySearch                Rank gene terms based on a discretized sentence relevancy to disease queries                                                                                                                                                                                                           

  GeneWanderer              Use text evidence to augment PPI networks                                                                                                                                                                                                                                              

  GPsy                      Extract phenotype annotation based on co-occurrence statistics in the biomedical literature                                                                                                                                                                                            

  With ontology structure   Tiffin et al.                                                                                                                                 Use the eVOC anatomical ontology to connect the PubMed literature and RefSeq genes                                                       Richer and hierarchical semantics from ontology, but accuracy depend on resolution, noise and irregularities from ontologies

  SUSPECTS                  Calculate semantic similarity between GO terms by exploring GO structure and how many times these GO terms occur in the Swiss-Prot database                                                                                                                                            

  MedSim                    Calculate semantic similarity between GO terms by exploring GO structure                                                                                                                                                                                                               

  Statistical text mining   GRAIL                                                                                                                                         Represent genes using a tf-idf weighted feature vector to analyze PubMed abstracts to calculate the gene-gene and gene-SNP correlation   More detailed and advanced modeling of text distributions opens the avenue to even richer semantic analysis. Requires large training corpus, time consuming

  Genie                     Train a Bayesian linear classifier that picks discriminative keywords to be used in orthologous gene abstract search                                                                                                                                                                   

  MetaRanker                Large-scale text mining on MEDLINE abstracts using customized statistical models of genes and MeSH terms adjusted for publication bias                                                                                                                                                 
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
